This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lamour, J. M. Articles by Hsu, D. T. Search for Related Content PubMed PubMed Citation Articles by Lamour, J. M. Articles by Hsu, D. T. Related Collections Other heart failure CV surgery: transplantation, ventricular assistance, cardiomyopathy

(Circulation. 1999;100:II-200.)
© 1999 American Heart Association, Inc.

Thoracic Transplantation and Ventricular Assist Devices

Outcome After Orthotopic Cardiac Transplantation in Adults With Congenital Heart Disease

Jacqueline M. Lamour, MD; Linda J. Addonizio, MD; Mark E. Galantowicz, MD; Jan M. Quaegebeur, MD; Donna M. Mancini, MD; Maryanne R. Kichuk, MD; Ainat Beniaminovitz, MD; Robert E. Michler, MD; Alan Weinberg, MS; Daphne T. Hsu, MD

From the Department of Pediatrics, Medicine and Surgery, College of Physicians and Surgeons, Columbia University, New York, NY. Dr Kichuk’s current address is Department of Pediatrics, Cleveland Clinic, Pediatric Cardiology Desk M-41, 9500 Euclid Ave, Cleveland, Ohio 44195. Dr Michler’s current address is Department of Surgery, Ohio State University, North Dorn Hall, 410 West 10th Ave, Columbus, Ohio 43210.

Correspondence to Jacqueline M. Lamour, MD, BCH 2 North, 3959 Broadway, New York, NY 10032. E-mail jml14{at}columbia.edu

Background—Advances in surgical and medical management have greatly improved long-term survival rates in patients with congenital heart disease (CHD). As these patients reach adulthood, myocardial dysfunction can occur, leading to cardiac transplantation.

Methods and Results—We reviewed the pretransplantation and posttransplantation courses of 24 patients >18 years old (mean age, 26 years; range, 18 to 56 years) with CHD who received a transplant between January 1985 and September 1998. The relation between preoperative and perioperative risk factors for complications and death was assessed. Single ventricle was the pretransplantation diagnosis for 12 patients (50%), and d-transposition of the great vessels was the diagnosis for 4 patients (16%). Twenty-two patients had a mean of 2 previous operations. At cardiac transplantation, additional surgical procedures were required to correct extracardiac lesions in 18 patients (75%). Refractory heart failure was present in 22 patients, significant cyanosis was present in 7, and protein-losing enteropathy was present in 4. There were 5 early deaths due to bleeding (n=3) and infection (n=2). The Kaplan-Meier survival rate after cardiac transplantation was 79% at 1 year and 60% at 5 years . No anatomic or surgical risk factor was predictive of death. The outcome of patients with CHD who received a transplant was compared with that for patients without CHD (n=788). Mean bypass and ischemic times were significantly longer in patients with CHD than in patients without CHD. Survival rates after transplantation did not differ significantly between patients with and those without CHD (P=0.83).

Conclusions—Successful cardiac transplantation is obtainable in adults with complex CHD, with an outcome similar to that of patients without CHD. A detailed assessment of cardiac anatomy and careful surgical planning are essential to the pretransplantation and posttransplantation management of these patients.

Key Words: transplantation • heart defects, congenital • risk factors